BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HEC88473 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HEC88473\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07616037-233@assetmemo.bio
DTSTAMP:20261121T005850Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:HEC88473: Phase 2 readout est. (NCT07616037)
DESCRIPTION:HEC88473\, phase 2.\nStudy: Efficacy of a GLP-1/FGF21 Dual Agon
 ist for Treating PCOS\nEstimated primary completion: June 2027. This is a 
 ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can mo
 ve.\nDrug page: https://assetmemo.bio/drug/hec88473#upcoming-events\nRegis
 try record: https://clinicaltrials.gov/study/NCT07616037
URL:https://assetmemo.bio/drug/hec88473#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
